Also, impaired HDL functionality and reduced apoA-I levels are acknowledged risk factors for autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), psoriasis, and atopic dermatitis [8,9,10]. Here, APOA1 is linked to systemic lupus erythematosus.